Abstract
Ergotism is a rare clinical condition caused by ergot-alkaloid intoxication or pharmacodynamic interactions. The pathophysiology is based on arterial spasm in different segments of the arterial tree. Ergot-alkaloids are frequently prescribed as treatment for severe migraine. Ergotamine overdose is often based on interactions with other drugs using the same metabolic pathway. We report a case of a 28 year old HIV positive male patient on protease-inhibitors, who developed ergotism under the co-treatment of migraine by ergot-alkaloids.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
